T1	Participants 651 662	participant
T2	Participants 797 804	patient
T3	Participants 1210 1252	Eighteen (18) patients completed the trial
T4	Participants 1310 1317	control
T5	Participants 1372 1379	control
T6	Participants 1330 1341	active drug
T7	Participants 1392 1396	drug
T8	Participants 1469 1473	drug
T9	Participants 1449 1456	control
